| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |